Metraipolis › archive › dc_d8ec0a8656cb
Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study — Europe PMC PMID:41089835
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41089835
- DOI
- 10.3389/fphar.2025.1642137
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T17:20:45.315Z
- SHA-256 of the archived text
6bfdee35ebec4d063dcd5eb513622307ff9e92e7848ae5effd4ddec127487379- Stable URL of this page
https://metraipolis.com/documento/dc_d8ec0a8656cb
How to cite
Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study — Europe PMC PMID:41089835 — Europe PMC (en), https://europepmc.org/article/MED/41089835 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8ec0a8656cb (Metraipolis archive dc_d8ec0a8656cb, sha256 6bfdee35ebec4d063dcd5eb513622307ff9e92e7848ae5effd4ddec127487379)
BibTeX
@misc{dcd8ec0a8656cb,
title = {Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study — Europe PMC PMID:41089835},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41089835},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8ec0a8656cb; sha256 6bfdee35ebec4d063dcd5eb513622307ff9e92e7848ae5effd4ddec127487379},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41089835. Agents can read the archived copy with the MCP tool read_document.